SCHEMBL6773174

SCHEMBL6773174

N=C(N)Nc1cccc(C(=O)NCC(=O)Nc2cc(Br)sc2CCC(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 4/20 0.41
ITGA2B P08514 3/20 0.41
HTT P42858 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
F10 P00742 1/20 0.37
RXFP1 Q9HBX9 1/20 0.36
ITGB1 P05556 2/20 0.36
ITGAV P06756 2/20 0.36
MDM4 O15151 1/20 0.36
ITGA5 P08648 1/20 0.36
MDM2 Q00987 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6783108 0.89 ITGB3 (0.41) ITGB3ITGA2BHTTL3MBTL1ALDH1A1
SCHEMBL6777675 0.89 ITGB3 (0.41) ITGB3ITGA2BHTTL3MBTL1ALDH1A1
SCHEMBL6777380 0.85 SMN1; SMN2 (0.44) ITGB3ITGA2BHTTL3MBTL1ALDH1A1
SCHEMBL6778336 0.83 HTT (0.41) ITGB3ITGA2BHTTL3MBTL1ALDH1A1
SCHEMBL7340459 0.83 ITGB3 (0.40) ITGB3ITGA2BHTTL3MBTL1ALDH1A1
SCHEMBL7346205 0.81 ITGB3 (0.40) ITGB3ITGA2BHTTL3MBTL1ALDH1A1
SCHEMBL7346500 0.80 ITGB3 (0.60) ITGB3ITGA2BHTTL3MBTL1ALDH1A1
SCHEMBL7348081 0.80 ITGB3 (0.43) ITGB3ITGA2BHTTL3MBTL1SMN1; SMN2
SCHEMBL7348024 0.79 ITGB3 (0.42) ITGB3ITGA2BHTTL3MBTL1SMN1; SMN2
SCHEMBL7340290 0.79 ITGB3 (0.42) ITGB3ITGA2BHTTL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP claimed
CN-1201454-A Meta-guanidino, ureido, thioureido or azacyclic aminobenzoic acid derivatives as integrin antagonists SEARLE & CO (US) 1998-12-09 CN claimed
US-6831199-B1 In order to avoid bleeding side-effects when treating the conditions associated with integrin alpha v beta 3, it is beneficial to have compounds which are selective antagonists for alpha v beta 3 versus alpha IIb beta 3 G. D. SEARLE & CO. 2004-12-14 US disclosed
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP disclosed
EP-0850221-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1998-07-01 EP disclosed
WO-1997008145-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1997-03-06 WO disclosed